Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuartix Tech Regulatory News (QTX)

Share Price Information for Quartix Tech (QTX)

Share Price is delayed by 15 minutes
Get Live Data
262.50    -2.50 (-0.94%)
Bid:
260.00
Ask:
265.00
Spread: 5.00 (1.923%)
Market Cap: £127.20m
QTX Live PriceLast checked at - London Stock Exchange

Intraday Quartix Tech Share Chart

Trading Statement

2 Jul 2018 07:00

RNS Number : 1610T
Quartix Holdings PLC
02 July 2018
 

2nd July 2018

Quartix Holdings plc

("Quartix" or the "Company")

Trading Statement

Quartix Holdings plc, a leading supplier of subscription-based vehicle tracking systems, software and services in the UK, announces that it will publish interim results for the six-month period ended 30 June 2018 on Wednesday 25 July 2018. They will be posted on the Company's website the same day, together with accompanying presentations.

The Company is pleased to report that trading to date has been in line with management's expectations for the year as a whole. For the six months ended 30 June 2018, the Company expects to report high single-digit growth in revenue compared with the same period last year, with profit broadly in-line with the same period last year, which includes the increased investment made by the Company in its international markets as it seeks to accelerate its international growth opportunities. Free cash flow for the period is anticipated to be slightly up against the equivalent period last year. These comparisons are given on a like-for-like basis, as the Group's profit and revenue will increase for 2017 and 2018 as a result of the Group's adoption of IFRS15 (Revenue from Contracts with Customers).

 Andy Walters, Chief Executive, commented:

 "We have made excellent progress in our international markets with our fleet business. New installations of tracking systems grew by 61% in France to 2820 vehicles, reaching a closing base of 15,390, and in the USA they increased by 62% to 3,400 vehicles, taking the base to 10,840 vehicles."

 "The subscription base for our UK business increased by 3.7% in the 6 months to 86,300. This reduced rate of growth compared to last year resulted from lower new installations of 9,000 vehicles. Management actions are already being taken to reverse the trend, alongside the growth initiatives underway in international markets."

 "As noted in our trading statement of 27 March, volumes in our insurance business were lower than they had been in the second half of 2017, although we saw some stabilisation of this towards the end of the second quarter. This stabilisation was, in large part, due to growth achieved in the Company's 'Powered by Quartix' direct offering to insurance brokers."

 "We will continue to invest in our fleet business in the second half and only add new insurance business if the quality of service and product innovation we offer are appropriately valued."

 

 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

For further information, please contact:

Quartix (www.quartix.net)

Andy Walters, Chief Executive Officer

Daniel Mendis, Chief Financial Officer

01686 806 663

finnCap (Nominated Adviser and Joint Broker)

Matt Goode/Scott Mathieson (Corporate Finance)

Alice Lane (Corporate Broking)

Cantor Fitzgerald (Joint Broker)

Marc Milmo/ Catherine Leftley

 

020 7220 0500

 

 

020 7894 7000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTMMGGNNMDGRZM
Date   Source Headline
2nd Jun 202612:17 pmRNSDirector/PDMR Shareholding
22nd Apr 20265:20 pmRNSResult of AGM
22nd Apr 20267:00 amRNSTrading Statement
8th Apr 202612:16 pmRNSDirector/PDMR Dealing, TVR & Investor Webinar
25th Mar 20267:00 amRNSFinal Results
20th Mar 20264:18 pmRNSNotice of Results
23rd Feb 20267:00 amRNSNotice of Results
11th Feb 20267:00 amRNSFRC Review, Accounting Policy & Notice of Results
8th Jan 20267:00 amRNSTrading Update
15th Dec 20255:47 pmRNSDirector/PDMR Shareholding
18th Nov 20252:15 pmRNSHolding(s) in Company
27th Oct 202512:49 pmRNSDirector/PDMR Shareholding
6th Oct 20255:37 pmRNSGrant of Options
6th Oct 20257:01 amRNS-RMelloMonday Investor Webinar
6th Oct 20257:00 amRNSTrading Statement
24th Jul 20257:00 amRNSInterim Results
3rd Jul 20257:00 amRNSTrading Statement
7th Apr 20257:00 amRNSTrading Statement
31st Mar 20253:52 pmRNSDirector/PDMR Shareholding
31st Mar 20251:30 pmRNSResult of AGM
31st Mar 20257:00 amRNSAGM Trading Statement
3rd Mar 20257:00 amRNSFinal Results
13th Feb 202510:00 amRNSInvestor Presentation via Investor Meet Company
13th Jan 20257:00 amRNSTrading Statement
15th Oct 20247:00 amRNSTrading Statement
28th Aug 202410:58 amRNSDirector/PDMR Shareholding
29th Jul 20247:00 amRNSInterim Results
8th Jul 20247:00 amRNSTrading Statement
15th May 20246:24 pmRNSGranting of Options
27th Mar 20244:00 pmRNSResult of AGM
27th Mar 20247:00 amRNSAGM Trading Statement and Directorate Change
4th Mar 20247:00 amRNSFinal Results
19th Feb 20247:00 amRNSDirectorate Changes
24th Jan 20245:45 pmRNSHolding(s) in Company
23rd Jan 20245:00 pmRNSDirector/PDMR Shareholding - Replacement
23rd Jan 20241:09 pmRNSDirector/PDMR Shareholding
17th Jan 20243:51 pmRNSHolding(s) in Company
17th Jan 20241:45 pmRNSHolding(s) in Company
9th Jan 20247:00 amRNSTrading Statement
18th Dec 202311:45 amRNSHolding(s) in Company
11th Dec 20237:00 amRNSKonetik update
28th Nov 20237:00 amRNSDirectorate Changes
10th Nov 20234:01 pmRNSDirector/PDMR Shareholding
11th Oct 20237:00 amRNSBoard Changes - Replacement
10th Oct 20235:00 pmRNSBoard Changes
6th Oct 20237:00 amRNSTrading Update
26th Sep 20237:00 amRNSDirectorate Change
21st Sep 202311:00 amRNSDirector/PDMR Shareholding
15th Sep 20237:00 amRNSAcquisition of Konetik GmBH
3rd Aug 20233:50 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.